Late stage clinical development plan for cladribine tablets in the treatment of multiple sclerosis

被引：0
|
作者：
Viglietta, V. [1 ]
Greenberg, S. [1 ]
Mikol, D. [1 ]
Weiner, J. [1 ]
Alteri, E. [1 ]
Chang, P. [1 ]
Krumwieh, D. [1 ]
Musch, B. [1 ]
机构：
[1] Merck Serono SA, Geneva, Switzerland
来源：
JOURNAL OF NEUROLOGY | 2010年 / 257卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P443
引用
收藏
页码：S143 / S144
页数：2
相关论文
共 50 条
  • [41] Cladribine in the treatment of relapsing multiple sclerosis
    Robles-Cedeno, Rene
    Ramio-Torrenta, Lluis
    REVISTA DE NEUROLOGIA, 2018, 67 (09) : 343 - 354
  • [42] CLADRIBINE TREATMENT OF MULTIPLE-SCLEROSIS
    REILLY, D
    LANCET, 1994, 344 (8921): : 537 - 537
  • [43] Real world experience with cladribine tablets for multiple sclerosis at four academic multiple sclerosis centers
    Conway, Devon S.
    Nicholas, Jacqueline A.
    Thompson, Nicolas R.
    Mowry, Ellen M.
    Naismith, Robert T.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 94
  • [44] Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets
    Cortese, Rosa
    Battaglini, Marco
    Sormani, Maria Pia
    Luchetti, Ludovico
    Gentile, Giordano
    Inderyas, Maira
    Alexandri, Nektaria
    De Stefano, Nicola
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (01) : 179 - 186
  • [45] Cladribine tablets in the treatment of patients with multiple sclerosis: an integrated analysis of infections in association with severe lymphopenia
    Cook, S.
    Leist, T.
    Comi, G.
    Montalban, X.
    Sylvester, E.
    Hicking, C.
    Dangond, F.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 299 - 300
  • [46] Mode of action (MoA) of cladribine tablets: activity in lymphocytes and implications for treatment of multiple sclerosis (MS)
    Leist, T.
    Weissert, R.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S206 - S206
  • [47] Reduction of Risk of Secondary Progressive Multiple Sclerosis Within Two Years of Treatment with Cladribine Tablets
    Vermersch, Patrick
    Giovannoni, Gavin
    Soelberg-Sorensen, Per
    Rammohan, Kottil
    Cook, Stuart
    Keller, Birgit
    Roy, Sanjeev
    NEUROLOGY, 2020, 94 (15)
  • [48] Cladribine tablets: a potential new short-course annual treatment for relapsing multiple sclerosis
    Sipe, Jack C.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (03) : 365 - 375
  • [49] Correction to: Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
    Renée Else Michels
    Maria De Francesco
    Koshu Mahajan
    Gerald J. D. Hengstman
    Krijn M. H. Schiffers
    Sangeeta Budhia
    Gerard Harty
    Marieke Krol
    Applied Health Economics and Health Policy, 2020, 18 : 141 - 141
  • [50] The CLARITY study (CLAdRIbine tablets Treating multiple sclerosis orallY): design of a Phase III trial of oral cladribine in relapsing multiple sclerosis
    Giovannoni, G.
    Comi, G.
    Cook, S.
    Beelke, M.
    Rieckmann, P.
    Sorensen, P. S.
    Vermersch, P.
    MULTIPLE SCLEROSIS, 2007, 13 : S245 - S245
12345